Literature DB >> 28668819

Calcium Pyrophosphate Crystal Inflammatory Arthritis (Pseudogout) with Myelodysplastic Syndrome: A New Paraneoplastic Syndrome?

Sara K Tedeschi1, Richard M Stone2, Simon M Helfgott3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28668819      PMCID： PMC6016375          DOI： 10.3899/jrheum.170106

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  8 in total

Review 1.  Calcium Pyrophosphate Deposition Disease.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

2.  Consecutive pseudogout attacks after repetitive granulocyte colony-stimulating factor administration for neutropenia.

Authors:  Paul R J Ames; Mervin G Rainey
Journal:  Mod Rheumatol       Date:  2007-10-19       Impact factor: 3.023

3.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

Review 4.  Recent developments in myelodysplastic syndromes.

Authors:  Rafael Bejar; David P Steensma
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

5.  EULAR recommendations for calcium pyrophosphate deposition. Part II: management.

Authors:  W Zhang; M Doherty; E Pascual; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; T Bardin
Journal:  Ann Rheum Dis       Date:  2011-01-20       Impact factor: 19.103

6.  European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.

Authors:  W Zhang; M Doherty; T Bardin; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; E Pascual
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

7.  Autoimmunity and Inflammation in Myelodysplastic Syndromes.

Authors:  Ofir Wolach; Richard Stone
Journal:  Acta Haematol       Date:  2016-06-24       Impact factor: 2.195

Review 8.  Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.

Authors:  Arsène Mekinian; Thorsten Braun; Olivier Decaux; Géraldine Falgarone; Eric Toussirot; Loic Raffray; Mohamed Omouri; Bruno Gombert; Benoit De Wazieres; Anne-Laure Buchdaul; Jean-Marc Ziza; David Launay; Guillaume Denis; Serge Madaule; Christian Rose; Eric Grignano; Pierre Fenaux; Olivier Fain
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889
  8 in total
  2 in total

1.  Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence.

Authors:  Katherine A Yates; Kazuki Yoshida; Chang Xu; Houchen Lyu; Vibeke Norvang; Daniel H Solomon; Sara K Tedeschi
Journal:  J Rheumatol       Date:  2019-11-01       Impact factor: 4.666

2.  Pseudogout: An Autoimmune Paraneoplastic Manifestation of Myelodysplastic Syndrome.

Authors:  Shumaila M Iqbal; Hafiz M Aslam; Faizan Faizee; Sana Qadir; Saadia Waheed
Journal:  Cureus       Date:  2018-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.